Sponsor
Analysis Group, Inc.
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Analysis Group, Inc. appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownExternal Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCNCT04697446 · collaborator · 2020-12-01
UNKNOWNContinuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed AdultsNCT04311957 · collaborator · 2020-09-01
UNKNOWNUnderstanding Patient Experience and Preferences for the QT Scanner Compared to MammographyNCT04057391 · collaborator · 2019-08-06
SUSPENDEDImmediate Fast-Track Versus Standard Care for Persons Living With HIV in HaitiNCT03358927 · collaborator · 2018-11-27
COMPLETEDSame-Day Treatment With Genvoya vs. EFV/TDF/3TCNCT03405194 · collaborator · 2018-05-01
WITHDRAWNA Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIVNCT03154320 · collaborator · 2017-11-06
COMPLETEDSponsor roles
collaborator6
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.